| Financial Year |
March 31 2023 |
| Monetary Funds |
7,281,505,000.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,578,194,000.00 |
| Advances to Suppliers |
97,853,000.00 |
| Other Receivables |
106,977,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,490,113,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
675,132,000.00 |
| Total Current Assets |
15,764,370,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,528,683,000.00 |
| Investment Properties |
333,032,000.00 |
| Fixed Assetes |
13,196,880,000.00 |
| Under-construction Projects |
2,462,953,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
367,648,000.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
703,313,000.00 |
| Deferred Income Tax Assets |
998,600,000.00 |
| Other Non-Current Assets |
3,262,634,000.00 |
| Sub-Total of Non-Current Assets |
24,873,548,000.00 |
| Total Assets |
40,637,918,000.00 |
| Short-Term Loans |
5,048,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
267,815,000.00 |
| Accounts Payable |
5,127,055,000.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
584,476,000.00 |
| Taxes Payable |
1,043,953,000.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,074,350,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,677,000.00 |
| Other Current Liabilities |
41,056,000.00 |
| Sub-Total of Current Liabilities |
13,538,833,000.00 |
| Long-term Loans |
700,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
32,389,000.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
873,058,000.00 |
| Total Liabilities |
14,411,891,000.00 |
| Paid-In Capital(Or Share Stock) |
10,799,286,000.00 |
| Capital Surplus |
609,166,000.00 |
| Surplus Reserve |
6,672,634,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,759,906,000.00 |
| Minority Stockholder's Interest |
128,475,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
26,097,552,000.00 |
| Owner's Equity（Stockholder's Equity） |
26,226,027,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
40,637,918,000.00 |
